Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / Endometriosis Blood Test An End to Years of Agony
Liquid biopsy Microbiology and Immunology Molecular Pathology Research and Innovations

Endometriosis Blood Test: An End to Years of Agony?

Multi-omic assay could reduce reliance on surgery and imaging

04/09/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Clinical Scorecard: Endometriosis Blood Test: An End to Years of Agony?

At a Glance

CategoryDetail
ConditionEndometriosis
Key MechanismsMulti-marker blood test combining microRNA, protein, and hormone measurements.
Target PopulationWomen of reproductive age, particularly those with infertility.
Care SettingClinical laboratory settings using established platforms.

Key Highlights

  • Accurate detection of endometriosis, including cases missed by standard imaging.
  • Addresses delayed diagnosis by offering a non-invasive testing option.
  • Utilizes machine learning to classify disease status based on biomarkers.
  • Demonstrates high diagnostic accuracy across different menstrual phases.
  • Identifies cases not detected by ultrasound or MRI, reducing false negatives.

Guideline-Based Recommendations

Diagnosis

  • Consider multi-marker blood test for symptomatic women to enhance diagnostic accuracy.

Management

  • Use blood test results to guide referral, imaging, or empirical treatment decisions.

Monitoring & Follow-up

  • Monitor disease status through periodic blood testing as part of ongoing care.

Risks

  • Invasive laparoscopy remains the gold standard; reliance on blood tests may require further validation.

Patient & Prescribing Data

Women with suspected endometriosis, particularly those experiencing infertility.

Early triage based on blood test results could lead to timely interventions.

Clinical Best Practices

  • Incorporate multi-omic diagnostics into clinical pathways for endometriosis.
  • Utilize established laboratory platforms for test implementation.
  • Adopt algorithm-driven diagnostics for interpreting complex biomarker patterns.

References

  • Journal of Minimally Invasive Gynecology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Light in the Darkness
Liquid biopsy
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

Biomarkers: The Bigger Picture
Liquid biopsy
Biomarkers: The Bigger Picture

April 27, 2022

1 min read

To unlock patient care, pathologists must focus on molecular pathology and ensure efficiency and effectiveness to improve testing. With this testing, patients can benefit from the best treatment to combat their disease.

Benchmarking… Liquid Biopsy
Liquid biopsy
Benchmarking… Liquid Biopsy

May 13, 2022

1 min read

A look at the last five years of publishing on liquid biopsy

Does Your Blood Know You Have Cancer?
Liquid biopsy
Does Your Blood Know You Have Cancer?

July 25, 2022

2 min read

Detection and monitoring are crucial for melanoma outcomes – could a blood test revolutionize both?

Affiliations:

Specialties:

Areas of Expertise:

View Full Profile Follow
Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.